Your session is about to expire
← Back to Search
Other
4 mg OTO-201 for Ear Tube Insertion
Phase 1
Waitlist Available
Research Sponsored by Otonomy, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month
Awards & highlights
Summary
The purpose of this study is to describe the safety and tolerability of two dose levels of OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.
Eligible Conditions
- Ear Tube Insertion
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Safety
Secondary outcome measures
Clinical Activity
Microbiological Eradication
Side effects data
From 2014 Phase 3 trial • 266 Patients • NCT019491428%
Pyrexia
7%
Nasopharyngitis
6%
Irritability
6%
Upper respiratory tract infection
6%
Teething
3%
Cough
1%
Bronchiolitis
1%
Gastroenteritis
100%
80%
60%
40%
20%
0%
Study treatment Arm
OTO-201 Single, Intratympanic Injection
Sham-Simulated Single, Intratympanic Injection
Trial Design
4Treatment groups
Experimental Treatment
Placebo Group
Group I: 4 mg OTO-201Experimental Treatment1 Intervention
Group II: 12 mg OTO-201Experimental Treatment1 Intervention
Group III: Vehicle for OTO-201Placebo Group1 Intervention
Group IV: ShamPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ciprofloxacin
FDA approved
Find a Location
Who is running the clinical trial?
Otonomy, Inc.Lead Sponsor
21 Previous Clinical Trials
2,996 Total Patients Enrolled
Carl LeBel, PhDStudy ChairOtonomy, Inc.
15 Previous Clinical Trials
1,666 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger